No. 23andMe is considered a direct-to-consumer genetic testing company, and transactions with the company are considered commercial, not medical. Because 23andMe is not a medical company, customers' ...

The restructuring arrives during a period of turmoil at California-based 23andMe, which has recently included a high-profile ...

The restructuring arrives during a period of turmoil at California-based 23andMe, which has recently included a high-profile ...

Home genetics company 23andMe continues to struggle as demand for casual gene tracing declines. On Monday, the company announced that it has decided on a restructuring ...

Also Read: Legal Battle Brews Over 23andMe’s Customer Data Breach Settlement And Arbitration Claimants The company is ...

RELATED: Southwest Airlines to offer buyouts at 18 airports, headquarters The restructuring arrives during a period of ...

By eliminating hundreds of jobs and stripping the therapeutic programs, 23andMe expects to save around $35 million. The company, once valued at $6 billion, experienced a severe drop in share prices ...

The restructuring arrives during a period of turmoil at California-based 23andMe, which has recently included a high-profile ...

23andMe may well be the quintessential 2010s-era tech-adjacent ... In the meantime, it continues to pay out a $30 million ...

The tech layoff wave is still going strong in 2024. Following significant workforce reductions in 2022 and 2023, this year has more than 130,000 job cuts across 457 companies, according to independent ...

In yet another blow to the DNA-testing industry, Atlas Biomed, a London-based genetic firm with links to Russia, has disappeared without any warning.